JP Morgan Chase
RGEN icon

JP Morgan Chase’s Repligen RGEN Stock Holding History

JP Morgan Chase’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3M Sell
128,221
-120,716
-48% -$16.9M ﹤0.01% 2374
2025
Q4 		$40.8M Sell
248,937
-24,511
-9% -$3.84M ﹤0.01% 1495
2025
Q3 		$36.6M Sell
273,448
-163,008
-37% -$19.8M ﹤0.01% 1623
2025
Q2 		$54.3M Buy
436,456
+243,977
+127% +$31M ﹤0.01% 1286
2025
Q1 		$24.5M Buy
192,479
+31,450
+20% +$4.84M ﹤0.01% 1759
2024
Q4 		$23.2M Sell
161,029
-202,470
-56% -$29M ﹤0.01% 1903
2024
Q3 		$54.1M Buy
363,499
+170,000
+88% +$24.4M ﹤0.01% 1284
2024
Q2 		$24.4M Buy
193,499
+24,309
+14% +$3.81M ﹤0.01% 1710
2024
Q1 		$31.1M Buy
169,190
+8,186
+5% +$1.56M ﹤0.01% 1580
2023
Q4 		$28.9M Sell
161,004
-20,989
-12% -$3.27M ﹤0.01% 1555
2023
Q3 		$28.9M Sell
181,993
-32,782
-15% -$5.36M ﹤0.01% 1415
2023
Q2 		$30.4M Buy
214,775
+6,218
+3% +$997K ﹤0.01% 1397
2023
Q1 		$35.1M Sell
208,557
-32,019
-13% -$5.71M ﹤0.01% 1276
2022
Q4 		$40.7M Sell
240,576
-6,902
-3% -$1.25M 0.01% 1217
2022
Q3 		$46.3M Sell
247,478
-12,593
-5% -$2.66M 0.01% 1071
2022
Q2 		$42.2M Buy
260,071
+4,526
+2% +$716K 0.01% 1140
2022
Q1 		$48.1M Sell
255,545
-20,678
-7% -$3.93M 0.01% 1183
2021
Q4 		$73.2M Sell
276,223
-36,087
-12% -$9.72M 0.01% 1023
2021
Q3 		$90.3M Buy
312,310
+63,844
+26% +$16.4M 0.01% 915
2021
Q2 		$49.6M Sell
248,466
-256,774
-51% -$49.8M 0.01% 1228
2021
Q1 		$98.2M Buy
505,240
+161,154
+47% +$33M 0.01% 852
2020
Q4 		$65.9M Buy
344,086
+192,161
+126% +$35M 0.01% 957
2020
Q3 		$22.9M Sell
151,925
-29,207
-16% -$4.17M ﹤0.01% 1419
2020
Q2 		$22.4M Buy
181,132
+66,059
+57% +$7.77M ﹤0.01% 1307
2020
Q1 		$11.1M Buy
115,073
+30,058
+35% +$2.9M ﹤0.01% 1659
2019
Q4 		$7.86M Buy
85,015
+22,798
+37% +$1.92M ﹤0.01% 2321
2019
Q3 		$4.77M Buy
62,217
+708
+1% +$61.9K ﹤0.01% 2733
2019
Q2 		$5.16M Buy
61,509
+49,211
+400% +$3.35M ﹤0.01% 2615
2019
Q1 		$727K Sell
12,298
-1,101
-8% -$63.3K ﹤0.01% 3989
2018
Q4 		$707K Sell
13,399
-1,120
-8% -$65.7K ﹤0.01% 3948
2018
Q3 		$805K Sell
14,519
-2,011
-12% -$104K ﹤0.01% 4036
2018
Q2 		$778K Buy
16,530
+258
+2% +$10.6K ﹤0.01% 3962
2018
Q1 		$588K Sell
16,272
-6,746
-29% -$237K ﹤0.01% 3943
2017
Q4 		$835K Buy
23,018
+16,417
+249% +$594K ﹤0.01% 3824
2017
Q3 		$249K Buy
6,601
+2,087
+46% +$87.5K ﹤0.01% 4043
2017
Q2 		$187K Buy
4,514
+759
+20% +$28.8K ﹤0.01% 4001
2017
Q1 		$133K Buy
3,755
+908
+32% +$28.8K ﹤0.01% 4217
2016
Q4 		$88K Buy
2,847
+1,047
+58% +$32.4K ﹤0.01% 4431
2016
Q3 		$54K Buy
1,800
+1,757
+4,086% +$53K ﹤0.01% 4023
2016
Q2 		$1K Hold
43
– – ﹤0.01% 4686
2016
Q1 		$1K Sell
43
-1,128
-96% -$27.6K ﹤0.01% 4580
2015
Q4 		$33K Buy
+1,171
New +$33.8K ﹤0.01% 3990
2015
Q3 		– Sell
-83,747
Closed -$3.46M – 4047
2015
Q2 		$3.46M Buy
+83,747
New +$3.07M ﹤0.01% 2610
2014
Q3 		– Sell
-16,139
Closed -$368K – 4239
2014
Q2 		$368K Buy
+16,139
New +$287K ﹤0.01% 3212

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase's RGEN Position: Q1 2026 in Review

JP Morgan Chase reduced its Repligen (RGEN) stake by 48% in Q1 2026, selling an estimated $16.9M and leaving 128,221 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2374.

JP Morgan Chase first reported a position in RGEN in Q2 2014 and has held it in 44 quarters since. The position peaked at $98.2M in Q1 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • JP Morgan Chase held 128,221 shares of Repligen worth $14.3M as of Q1 2026.
  • JP Morgan Chase sold 120,716 Repligen shares in Q1 2026, an estimated $16.9M.
  • Repligen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2374 holding.
  • JP Morgan Chase first reported a position in Repligen in Q2 2014 and has held it in 44 quarters since.
  • JP Morgan Chase's Repligen position peaked at $98.2M in Q1 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.